131 related articles for article (PubMed ID: 38335756)
1. Thiazolidine-2,4-dione derivatives as potential α-glucosidase inhibitors: Synthesis, inhibitory activity, binding interaction and hypoglycemic activity.
Li M; Sun J; Liang B; Min X; Hu J; Wu R; Xu X
Bioorg Chem; 2024 Mar; 144():107177. PubMed ID: 38335756
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of indole derivatives containing thiazolidine-2,4-dione as α-glucosidase inhibitors with antidiabetic activity.
Hu C; Liang B; Sun J; Li J; Xiong Z; Wang SH; Xuetao X
Eur J Med Chem; 2024 Jan; 264():115957. PubMed ID: 38029465
[TBL] [Abstract][Full Text] [Related]
3. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in-vitro α-glucosidase inhibition, antioxidant, in-vivo antidiabetic and molecular docking studies of pyrrolidine-2,5-dione and thiazolidine-2,4-dione derivatives.
Hussain F; Khan Z; Jan MS; Ahmad S; Ahmad A; Rashid U; Ullah F; Ayaz M; Sadiq A
Bioorg Chem; 2019 Oct; 91():103128. PubMed ID: 31369977
[TBL] [Abstract][Full Text] [Related]
5. 3,5-Disubstituted-thiazolidine-2,4-dione hybrids as antidiabetic agents: Design, synthesis, in-vitro and In vivo evaluation.
Singh G; Singh R; Monga V; Mehan S
Eur J Med Chem; 2024 Feb; 266():116139. PubMed ID: 38252989
[TBL] [Abstract][Full Text] [Related]
6. Identification of 1,3,4-oxadiazolyl-containing β-carboline derivatives as novel α-glucosidase inhibitors with antidiabetic activity.
Xiao D; Lu L; Liang B; Xiong Z; Xu X; Chen WH
Eur J Med Chem; 2023 Dec; 261():115795. PubMed ID: 37688939
[TBL] [Abstract][Full Text] [Related]
7. Anti-α-Glucosidase, SAR Analysis, and Mechanism Investigation of Indolo[1,2-b]isoquinoline Derivatives.
Li M; Li L; Lu L; Xu X; Hu J; Peng JB
Molecules; 2023 Jul; 28(13):. PubMed ID: 37446942
[TBL] [Abstract][Full Text] [Related]
8. Discovery of new 2-phenyl-1H-benzo[d]imidazole core-based potent α-glucosidase inhibitors: Synthesis, kinetic study, molecular docking, and in vivo anti-hyperglycemic evaluation.
Li Y; Zhang JH; Xie HX; Ge YX; Wang KM; Song ZL; Zhu KK; Zhang J; Jiang CS
Bioorg Chem; 2021 Dec; 117():105423. PubMed ID: 34717239
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, biological evaluation, and docking study of chromone-based phenylhydrazone and benzoylhydrazone derivatives as antidiabetic agents targeting α-glucosidase.
Fan M; Yang W; Liu L; Peng Z; He Y; Wang G
Bioorg Chem; 2023 Mar; 132():106384. PubMed ID: 36696731
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, biological evaluation, and docking study of new triazole-phenylacetamide derivatives as α-glucosidase inhibitors.
Luo S; Yang W; Huang Y; Peng Z; Wang G
Bioorg Chem; 2023 Dec; 141():106844. PubMed ID: 37703743
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, α-glucosidase and α-amylase inhibitory activities, acute toxicity and molecular docking studies of thiazolidine-2,4-diones derivatives.
Fettach S; Thari FZ; Hafidi Z; Tachallait H; Karrouchi K; El Achouri M; Cherrah Y; Sefrioui H; Bougrin K; Faouzi MEA
J Biomol Struct Dyn; 2022 Nov; 40(18):8340-8351. PubMed ID: 33847536
[TBL] [Abstract][Full Text] [Related]
12. Chromone-based benzohydrazide derivatives as potential α-glucosidase inhibitor: Synthesis, biological evaluation and molecular docking study.
Fan M; Yang W; Peng Z; He Y; Wang G
Bioorg Chem; 2023 Feb; 131():106276. PubMed ID: 36434950
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as α-glucosidase inhibitors.
Ritu ; Sharma P; Gupta GD; Asati V
Bioorg Chem; 2023 Oct; 139():106750. PubMed ID: 37499530
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li X; Li J
Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
[TBL] [Abstract][Full Text] [Related]
15. Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition.
Gummidi L; Kerru N; Ebenezer O; Awolade P; Sanni O; Islam MS; Singh P
Bioorg Chem; 2021 Oct; 115():105210. PubMed ID: 34332231
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.
Abdellatif KRA; Fadaly WAA; Kamel GM; Elshaier YAMM; El-Magd MA
Bioorg Chem; 2019 Feb; 82():86-99. PubMed ID: 30278282
[TBL] [Abstract][Full Text] [Related]
17. New cycloalkyl[b]thiophenylnicotinamide-based α-glucosidase inhibitors as promising anti-diabetic agents: Synthesis, in silico study, in vitro and in vivo evaluations.
Wang KM; Ge YX; Zhang J; Chen YT; Zhang NY; Gu JS; Fang L; Zhang XL; Zhang J; Jiang CS
Bioorg Med Chem Lett; 2023 Jan; 79():129069. PubMed ID: 36395995
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel (E)-2-benzylidene-N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)hydrazine-1-carboxamide derivatives as α-glucosidase inhibitors.
Zhang JH; Xie HX; Li Y; Wang KM; Song Z; Zhu KK; Fang L; Zhang J; Jiang CS
Bioorg Med Chem Lett; 2021 Nov; 52():128413. PubMed ID: 34634473
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory activity evaluation and mechanistic studies of tetracyclic oxindole derivatives as α-glucosidase inhibitors.
Sun H; Zhang Y; Ding W; Zhao X; Song X; Wang D; Li Y; Han K; Yang Y; Ma Y; Wang R; Wang D; Yu P
Eur J Med Chem; 2016 Nov; 123():365-378. PubMed ID: 27487567
[TBL] [Abstract][Full Text] [Related]
20. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
Asgari MS; Mohammadi-Khanaposhtani M; Kiani M; Ranjbar PR; Zabihi E; Pourbagher R; Rahimi R; Faramarzi MA; Biglar M; Larijani B; Mahdavi M; Hamedifar H; Hajimiri MH
Bioorg Chem; 2019 Nov; 92():103206. PubMed ID: 31445191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
